The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
08/03/2016 | Managing Intellectual Property Blog
1 min
July 03, 2025
July 02, 2025
July 01, 2025
July 16, 2025 Beverly Hills Bar Association
July 07, 2025
June 27, 2025
June 25, 2025